AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
189.02
-0.29 (-0.15%)
At close: Jul 31, 2025, 4:00 PM
188.80
-0.22 (-0.12%)
After-hours: Jul 31, 2025, 7:54 PM EDT

Company Description

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.

The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta/Venclyxto to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma.

It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic to treat neurologic diseases; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duopa and Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; and Qulipta for episodic and chronic migraine, as well as other neuroscience products.

In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products.

Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation.

The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

AbbVie Inc.
AbbVie logo
CountryUnited States
Founded2012
IndustryDrug Manufacturers - General
SectorHealthcare
Employees55,000
CEORobert Michael

Contact Details

Address:
1 North Waukegan Road
North Chicago, Illinois 60064-6400
United States
Phone847 932 7900
Websiteabbvie.com

Stock Details

Ticker SymbolABBV
ExchangeNYSE
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001551152
CUSIP Number00287Y109
ISIN NumberUS00287Y1091
Employer ID32-0375147
SIC Code2834

Key Executives

NamePosition
Scott T. ReentsExecutive Vice President and Chief Financial Officer
Dr. Azita Saleki-Gerhardt Ph.D.Executive Vice President and Chief Operating Officer
Jeffrey Ryan StewartExecutive Vice President and Chief Commercial Officer
Dr. Roopal Thakkar M.D.Executive Vice President of Research and Development and Chief Scientific Officer
Elizabeth SheaSenior Vice President of Investor Relations
Perry C. SiatisExecutive Vice President, General Counsel and Secretary
Demetris D. CrumExecutive Vice President and Chief Human Resources Officer
Wulff-Erik von BorckeSenior Vice President and President of Oncology
Dr. Nicholas J. Donoghoe M.D.Executive Vice President and Chief Business and Strategy Officer
Tracie HaasSenior Vice President of Corporate Affairs

Latest SEC Filings

DateTypeTitle
Jul 31, 20258-KCurrent Report
Jul 11, 20253Initial statement of beneficial ownership of securities
Jul 7, 2025SCHEDULE 13G/AFiling
Jul 3, 20258-KCurrent Report
Jun 13, 202511-KAnnual report of employee stock purchase, savings and similar plans
May 30, 2025SDForm - SD
May 13, 20258-KCurrent Report
May 9, 202510-QQuarterly Report
Apr 25, 20258-KCurrent Report
Apr 3, 20258-KCurrent Report